NRBO - שווי כולל של החברה NeuroBo Pharmaceuticals

This price visualization of the individual enterprise value for NeuroBo Pharmaceuticals (NRBO) on GURU.Markets recorded a figure of . The financial success of NeuroBo Pharmaceuticals (NRBO) is based on the market launch of treatments for obesity and steatohepatitis. The company's development is constrained by the framework of FDA-supervised clinical trials, while a steady inflow of capital is secured by a staff of top neurobiologists attracted by competitive employment terms.

Enterprise value represents the total acquisition cost of a business, combining market capitalization with net debt minus liquid assets. By analyzing the market value of the business adjusted for net debt, an investor sees the actual costs of acquiring NeuroBo Pharmaceuticals (NRBO), which are currently influenced by geopolitical risks and biomaterial supply chain disruptions that are slowing the release of neurological drugs.